Warrants Finder
Your selection:
426 Results
| FE58VL | Vertex Pharmaceuticals Inc./OS/Call [540]/SOC | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 39.212% | 0.538 | -0.063 | 3.308 | 01/21/2028 | 0.100 | Société Générale | ||
| GU8N65 | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 37.745% | 0.193 | -0.110 | 12.900 | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GW319X | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 39.494% | 0.523 | -0.063 | 3.337 | 01/21/2028 | 0.100 | Goldman Sachs | ||
| GW31A2 | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 36.600% | 0.356 | -0.090 | 6.622 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GW319Z | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 37.374% | 0.427 | -0.086 | 5.304 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW31CG | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 36.837% | 0.467 | -0.076 | 4.525 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GW97TA | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 36.445% | 0.329 | -0.093 | 7.376 | 12/18/2026 | 0.100 | Goldman Sachs | ||
| GW97Y1 | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 34.990% | 0.234 | -0.096 | 10.929 | 10/16/2026 | 0.100 | Goldman Sachs | ||
| GW980E | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 44.160% | 0.139 | -0.135 | 16.441 | 08/21/2026 | 0.100 | Goldman Sachs | ||
| MJ8K5R |  | Vertex Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 39.817% | 0.347 | -0.010 | 6.692 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MK9KV1 | | Vertex Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 40.601% | 0.465 | -0.008 | 4.195 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MM7P4T | | Vertex Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 44.908% | 0.238 | -0.015 | 10.369 | 09/18/2026 | 0.010 | Morgan Stanley | |
| MN04AG | | Vertex Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 43.010% | 0.543 | -0.007 | 3.147 | 12/17/2027 | 0.010 | Morgan Stanley | |
| MN6FTC | | Vertex Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 40.364% | 0.422 | -0.009 | 5.007 | 03/19/2027 | 0.010 | Morgan Stanley | |
| SX5KSP | Vertex Pharmaceuticals Inc./OS/Call [550]/SOC | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 37.814% | 0.230 | -0.125 | 12.171 | 09/18/2026 | 0.100 | Société Générale | ||
| FA53KB | Vertex Pharmaceuticals Inc./OS/Call [550]/SOC | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 39.128% | 0.346 | -0.102 | 6.805 | 12/18/2026 | 0.100 | Société Générale | ||
| FE58U7 | Vertex Pharmaceuticals Inc./OS/Call [550]/SOC | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 39.503% | 0.489 | -0.070 | 3.803 | 09/17/2027 | 0.100 | Société Générale | ||
| FE58VB | Vertex Pharmaceuticals Inc./OS/Call [550]/SOC | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 39.120% | 0.511 | -0.064 | 3.482 | 12/17/2027 | 0.100 | Société Générale | ||
| VY41Y1 | | Vertex Pharmaceuticals Inc./OS/Call [550]/VONT | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 38.836% | 0.476 | -0.080 | 4.298 | 06/17/2027 | 0.100 | Vontobel | |
| VY58SL | | Vertex Pharmaceuticals Inc./OS/Call [550]/VONT | - | - | 550.000 | call | Vertex Pharmaceuticals Inc. | - | 39.251% | 0.199 | -0.116 | 12.327 | 09/18/2026 | 0.100 | Vontobel | |
| GW92KX | Vertex Pharmaceuticals Inc./OS/Call [560]/GOLDS | - | - | 560.000 | call | Vertex Pharmaceuticals Inc. | - | 37.225% | 0.380 | -0.081 | 5.587 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| JY0J9S | Vertex Pharmaceuticals Inc./OS/Call [560]/JPMD | - | - | 560.000 | call | Vertex Pharmaceuticals Inc. | - | 40.262% | 0.353 | -0.107 | 6.570 | 12/18/2026 | 0.100 | JP Morgan | ||
| JY1U87 | Vertex Pharmaceuticals Inc./OS/Call [560]/JPMD | - | - | 560.000 | call | Vertex Pharmaceuticals Inc. | - | 40.109% | 0.349 | -0.096 | 6.157 | 01/15/2027 | 0.100 | JP Morgan | ||
| JY30ED | Vertex Pharmaceuticals Inc./OS/Call [560]/JPMD | - | - | 560.000 | call | Vertex Pharmaceuticals Inc. | - | 42.778% | 0.432 | -0.097 | 4.716 | 03/19/2027 | 0.100 | JP Morgan | ||
| SX5K5H | Vertex Pharmaceuticals Inc./OS/Call [560]/SOC | - | - | 560.000 | call | Vertex Pharmaceuticals Inc. | - | 38.788% | 0.345 | -0.093 | 6.367 | 01/15/2027 | 0.100 | Société Générale | ||
| FE1AXR | Vertex Pharmaceuticals Inc./OS/Call [560]/SOC | - | - | 560.000 | call | Vertex Pharmaceuticals Inc. | - | 37.351% | 0.308 | -0.092 | 7.383 | 12/18/2026 | 0.100 | Société Générale | ||
| FE1AXW | Vertex Pharmaceuticals Inc./OS/Call [560]/SOC | - | - | 560.000 | call | Vertex Pharmaceuticals Inc. | - | 39.433% | 0.393 | -0.086 | 5.249 | 03/19/2027 | 0.100 | Société Générale | ||
| VH91A6 | | Vertex Pharmaceuticals Inc./OS/Call [560]/VONT | - | - | 560.000 | call | Vertex Pharmaceuticals Inc. | - | 37.913% | 0.339 | -0.091 | 6.538 | 01/15/2027 | 0.100 | Vontobel | |
| GW95JG | Vertex Pharmaceuticals Inc./OS/Call [580]/GOLDS | - | - | 580.000 | call | Vertex Pharmaceuticals Inc. | - | 36.749% | 0.356 | -0.080 | 5.773 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| JY1LSH | Vertex Pharmaceuticals Inc./OS/Call [580]/JPMD | - | - | 580.000 | call | Vertex Pharmaceuticals Inc. | - | 39.908% | 0.306 | -0.090 | 6.474 | 01/15/2027 | 0.100 | JP Morgan | ||
| JY18HF | Vertex Pharmaceuticals Inc./OS/Call [580]/JPMD | - | - | 580.000 | call | Vertex Pharmaceuticals Inc. | - | 40.468% | 0.379 | -0.089 | 5.201 | 03/19/2027 | 0.100 | JP Morgan | ||
| SX5K5J | Vertex Pharmaceuticals Inc./OS/Call [580]/SOC | - | - | 580.000 | call | Vertex Pharmaceuticals Inc. | - | 37.894% | 0.288 | -0.083 | 6.901 | 01/15/2027 | 0.100 | Société Générale | ||
| FE1AXM | Vertex Pharmaceuticals Inc./OS/Call [580]/SOC | - | - | 580.000 | call | Vertex Pharmaceuticals Inc. | - | 39.059% | 0.121 | -0.081 | 13.931 | 09/18/2026 | 0.100 | Société Générale | ||
| GJ8XF1 | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 36.669% | 0.206 | -0.072 | 8.445 | 12/18/2026 | 0.100 | Goldman Sachs | ||
| GJ9UEX | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 36.644% | 0.237 | -0.072 | 7.538 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GV70QS | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 42.098% | 0.101 | -0.075 | 13.472 | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GV87KD | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 35.956% | 0.345 | -0.066 | 5.209 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GW01FF | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 38.740% | 0.448 | -0.061 | 3.626 | 01/21/2028 | 0.100 | Goldman Sachs | ||
| GW1W77 | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 36.842% | 0.294 | -0.071 | 6.159 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW82R8 | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 37.837% | 0.128 | -0.068 | 11.797 | 10/16/2026 | 0.100 | Goldman Sachs | ||
| GW8MXZ | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 52.153% | 0.070 | -0.089 | 16.061 | 08/21/2026 | 0.100 | Goldman Sachs | ||
| JY2JGS | Vertex Pharmaceuticals Inc./OS/Call [600]/JPMD | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 39.746% | 0.264 | -0.083 | 6.802 | 01/15/2027 | 0.100 | JP Morgan | ||
| MJ860W | | Vertex Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 41.185% | 0.244 | -0.009 | 7.275 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MK9KV2 | | Vertex Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 39.616% | 0.372 | -0.007 | 4.681 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MM5JP0 | | Vertex Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 51.916% | 0.156 | -0.013 | 10.112 | 09/18/2026 | 0.010 | Morgan Stanley | |
| MN04AH | | Vertex Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 42.253% | 0.457 | -0.007 | 3.451 | 12/17/2027 | 0.010 | Morgan Stanley | |
| MN6FTD | | Vertex Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 41.003% | 0.342 | -0.009 | 5.340 | 03/19/2027 | 0.010 | Morgan Stanley | |
| SX5K5K | Vertex Pharmaceuticals Inc./OS/Call [600]/SOC | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 38.678% | 0.252 | -0.079 | 7.058 | 01/15/2027 | 0.100 | Société Générale | ||
| SX5KSQ | Vertex Pharmaceuticals Inc./OS/Call [600]/SOC | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 42.093% | 0.101 | -0.075 | 13.474 | 09/18/2026 | 0.100 | Société Générale | ||
| FE1AXX | Vertex Pharmaceuticals Inc./OS/Call [600]/SOC | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 39.169% | 0.312 | -0.078 | 5.733 | 03/19/2027 | 0.100 | Société Générale |